Etastyle 125 Injection, containing Ethamsylate BP 125 mg, is an essential hemostatic agent that plays a vital role in the management of bleeding from small blood vessels. It works by enhancing platelet adhesion and strengthening capillary walls, thereby reducing the excessive bleeding often seen in various medical and surgical conditions. Unlike other coagulation agents, Ethamsylate specifically targets microvascular bleeding without affecting the overall blood coagulation process. This makes it a safe and reliable choice for preventing and treating bleeding associated with surgical procedures, heavy menstrual periods, and other spontaneous hemorrhagic conditions.
The market for hemostatic and bleeding control agents is a stable and high-demand segment within the Indian pharmaceutical industry. With the increasing number of surgical and gynecological procedures, the need for a reliable product like Etastyle 125 Injection is consistently high. This medication is a staple in hospitals, clinics, and surgical centers, ensuring a continuous prescription and institutional demand. Its essential nature makes it a high-turnover product, representing a strategic and highly profitable addition to any B2B pharma portfolio.
We are dedicated to empowering our franchise partners with all the tools necessary for success in this professional market. Our product is manufactured in a WHO-GMP certified facility, ensuring impeccable quality, efficacy, and safety, which is crucial for building trust with healthcare professionals and institutions. We provide a complete promotional and marketing kit, including detailed product literature, to support your sales efforts. Our robust supply chain guarantees timely delivery and continuous stock availability, preventing any business interruptions. Partner with us to enter this stable and highly profitable market and establish a reputable and successful business as a key supplier of this top-quality and essential medicine.